Examining the Potential Price Growth of Bausch Health Companies Inc (BHC)

In a filing, Bausch Health Companies Inc revealed its EVP, General Counsel Carson Seana unloaded Company’s shares for reported $61867.0 on Mar 04 ’24. In the deal valued at $9.80 per share,6,313 shares were sold. As a result of this transaction, Carson Seana now holds 499,905 shares worth roughly $5.1 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Carson Seana sold 220 shares, generating $1,624 in total proceeds. Upon selling the shares at $7.38, the EVP, General Counsel now owns 382,925 shares.

Before that, Carson Seana sold 43 shares. Bausch Health Companies Inc shares valued at $327 were divested by the EVP, General Counsel at a price of $7.61 per share. As a result of the transaction, Carson Seana now holds 384,836 shares, worth roughly $3.93 million.

Jefferies upgraded its Bausch Health Companies Inc [BHC] rating to a Buy from a a Hold in a research note published on September 20, 2023; the price target was increased to $16 from $9. A number of analysts have revised their coverage, including TD Cowen’s analysts, who decreased its forecast for the stock in mid June from “an Outperform” to “a Market perform”. Truist also remained covering BHC and has decreased its forecast on July 29, 2022 with a “Hold” recommendation from previously “Buy” rating. RBC Capital Mkts revised its rating on July 29, 2022. It rated BHC as “a Sector perform” which previously was an “an Outperform”.

Price Performance Review of BHC

On Tuesday, Bausch Health Companies Inc [NYSE:BHC] saw its stock fall -1.92% to $10.20. Over the last five days, the stock has gained 7.59%. Bausch Health Companies Inc shares have risen nearly 27.18% since the year began. Nevertheless, the stocks have risen 32.30% over the past one year. While a 52-week high of $10.80 was reached on 03/28/24, a 52-week low of $5.57 was recorded on 01/03/24. SMA at 50 days reached $8.95, while 200 days put it at $8.19. A total of 1.46 million shares were traded, compared to the trading of 3.82 million shares in the previous session.

Levels Of Support And Resistance For BHC Stock

The 24-hour chart illustrates a support level at 10.09, which if violated will result in even more drops to 9.97. On the upside, there is a resistance level at 10.28. A further resistance level may holdings at 10.36. The Relative Strength Index (RSI) on the 14-day chart is 64.35, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.68, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 33.99%. Stochastics %K at 77.53% indicates the stock is a holding.

How much short interest is there in Bausch Health Companies Inc?

A steep rise in short interest was recorded in Bausch Health Companies Inc stocks on Mar 15, 2024, growing by 2.25 million shares to a total of 23.78 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 21.53 million shares. There was a rise of 9.46%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 7.08% of the overall stock float, the days-to-cover ratio (short ratio) rose to 9.

Most Popular